Afinitor Approval Expanded to Include Benign Kidney Tumors
FRIDAY, April 27 (Healthday News) -- Afinitor (everolimus) is the first drug to be approved by the U.S. Food And Drug Administration to treat benign kidney tumors among people with a rare genetic condition called tuberous sclerosis complex (TSC), the agency said in a news release. read more..
source:http://yhoo.it/J7n2eT
No comments:
Post a Comment